AI Startup Clinches £10m to Tackle NHS Administration Crisis

Frontier Health, a London healthcare technology company, has raised £9.7 million in its latest funding round, taking its total capital raised since founding to £11.9 million. The round was led by Atomico, the European venture capital firm whose past backing includes Klarna and DeepL, with additional participation from XYZ Venture Capital and Firstminute Capital.

The company plans to use the new funding to expand its presence across NHS trusts and grow its workforce, currently 12 people, as it pushes its software further into hospital administration departments.

Frontier Health's launch comes against a backdrop of mounting strain on healthcare systems worldwide. Projections cited by the company point to a global shortfall of 10 million healthcare workers by 2030, a gap that has pushed hospitals and policymakers to look for ways of stretching existing staff further rather than simply hiring more of them.

Its product, an AI agent named Juno, is built to sit alongside NHS administrative teams rather than replace them. The software automates routine clerical work, including scheduling patient appointments, and flags potential operational risks with the aim of keeping patients moving through hospital systems without unnecessary delay. When Juno encounters a case it cannot interpret, such as ambiguous or incomplete data, it hands the task to a human administrator rather than attempting to resolve it independently. The company presents this as a deliberate safeguard, intended to keep a person in the loop on anything outside the system's competence.

Frontier Health was founded in 2024 by Rachel Finegold, its chief executive, who previously worked as a healthcare executive deploying data systems across more than 40 NHS hospitals during the Covid-19 pandemic. Finegold has said that period left her with a clear view of the pressure facing clerical teams, describing administrative bottlenecks and a lack of staff capacity as a direct obstacle to patients receiving timely care. That experience, she has said, shaped the company's focus on the operational side of hospital work rather than on clinical decision-making.

The technology is already in use. East Sussex Healthcare NHS Trust is named as an active client, marking one of the clearer examples of Frontier Health's software being deployed in a live hospital setting rather than tested in isolation.

The funding round reflects a wider pattern among investors, who increasingly view software that supports stretched public sector teams as a form of critical infrastructure rather than a peripheral add-on. Atomico and its co-investors have framed the bet on Frontier Health in similar terms, betting that demand for this kind of supportive AI will grow as health systems face continued workforce pressure.

That said, the presence of private technology firms inside the NHS remains contentious. More than half of NHS trusts in England already use software from a major external data firm to manage waiting lists, yet that arrangement has drawn sustained criticism from bodies including the British Medical Association, which has raised concerns over data privacy, transparency and the company's wider corporate ties. The BMA has previously called for the NHS to reconsider such partnerships altogether, arguing that public trust in how patient data is handled cannot be taken for granted.

Frontier Health's pitch differs in scope. Juno is designed to work on administrative tasks rather than to hold or process clinical records at scale, a distinction the company is likely to lean on as it seeks wider adoption across the health service. Whether that distinction insulates it from the scrutiny faced by larger data firms operating in the NHS remains to be seen, particularly as it expands beyond its current single trust deployment into a sector where any new entrant handling patient-facing systems can expect close examination.